AR127708A1 - Método para detectar biomarcadores de arn - Google Patents

Método para detectar biomarcadores de arn

Info

Publication number
AR127708A1
AR127708A1 ARP220103170A ARP220103170A AR127708A1 AR 127708 A1 AR127708 A1 AR 127708A1 AR P220103170 A ARP220103170 A AR P220103170A AR P220103170 A ARP220103170 A AR P220103170A AR 127708 A1 AR127708 A1 AR 127708A1
Authority
AR
Argentina
Prior art keywords
hdac6
tetrazol
thiophen
benzamide
inhibitors
Prior art date
Application number
ARP220103170A
Other languages
English (en)
Spanish (es)
Inventor
Gianluca Fossati
Chiara Ripamonti
Christian Steinkhler
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of AR127708A1 publication Critical patent/AR127708A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00—Nucleic acid detection characterised by assay method
    • C12Q2561/101—Taqman
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ARP220103170A 2021-11-23 2022-11-17 Método para detectar biomarcadores de arn AR127708A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT202100029558 2021-11-23

Publications (1)

Publication Number Publication Date
AR127708A1 true AR127708A1 (es) 2024-02-21

Family

ID=80121649

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103170A AR127708A1 (es) 2021-11-23 2022-11-17 Método para detectar biomarcadores de arn

Country Status (9)

Country Link
US (1) US20250011878A1 (enExample)
EP (1) EP4437138A1 (enExample)
JP (1) JP2024543138A (enExample)
KR (1) KR20240105468A (enExample)
CN (1) CN118202068A (enExample)
AR (1) AR127708A1 (enExample)
CA (1) CA3235259A1 (enExample)
TW (1) TW202340480A (enExample)
WO (1) WO2023094365A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080842A1 (en) * 2023-10-11 2025-04-17 Dana-Farber Cancer Institute, Inc. Methods of cancer detection, prediction of response to therapy, and treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018499A2 (en) * 2010-08-05 2012-02-09 Acetylon Pharmaceuticals Specific regulation of cytokine levels by hdac6 inhibitors
US20120176076A1 (en) 2011-01-10 2012-07-12 Carl Mansfield Methods and systems for powering auxiliary devices in photovol taic system
WO2014032899A1 (en) * 2012-08-31 2014-03-06 Novo Nordisk A/S Diagnosis and treatment of lupus nephritis
EP3084446B1 (en) * 2013-12-20 2022-12-14 Acetylon Pharmaceuticals, Inc. Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
CA2995520A1 (en) * 2015-08-14 2017-02-23 Hendrik Jan VAN OOIJEN Assessment of nfkb cellular signaling pathway activity using mathematical modelling of target gene expression
WO2017070441A1 (en) * 2015-10-23 2017-04-27 Icahn School Of Medicine At Mount Sinai Identifying and treating cancer patients who are suitable for a targeted therapy using an hdac6 inhibitor
IT201700041723A1 (it) 2017-04-14 2018-10-14 Italfarmaco Spa Nuovi inibitori selettivi di HDAC6

Also Published As

Publication number Publication date
JP2024543138A (ja) 2024-11-19
CA3235259A1 (en) 2023-06-01
US20250011878A1 (en) 2025-01-09
WO2023094365A1 (en) 2023-06-01
TW202340480A (zh) 2023-10-16
CN118202068A (zh) 2024-06-14
KR20240105468A (ko) 2024-07-05
EP4437138A1 (en) 2024-10-02

Similar Documents

Publication Publication Date Title
Coryell et al. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis
Zhang et al. Reprogramming of mitochondrial respiratory chain complex by targeting SIRT3‐COX4I2 axis attenuates osteoarthritis progression
Fosang et al. Drug insight: aggrecanases as therapeutic targets for osteoarthritis
McClung et al. Calpain-1 is required for hydrogen peroxide-induced myotube atrophy
Gregory et al. ASIC3 is required for development of fatigue-induced hyperalgesia
Nader et al. Resistance exercise training modulates acute gene expression during human skeletal muscle hypertrophy
Lubis et al. Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise
Crespo et al. Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice
EA200900927A1 (ru) Способы определения устойчивости рака к ингибиторам гистондеацетилазы
Karagiannis et al. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments
Choudhury et al. Proline restores mitochondrial function and reverses aging hallmarks in senescent cells
Andarawis‐Puri et al. Molecular response of the patellar tendon to fatigue loading explained in the context of the initial induced damage and number of fatigue loading cycles
Genemaras et al. Inflammatory cytokines induce specific time‐and concentration‐dependent MicroRNA release by chondrocytes, synoviocytes, and meniscus cells
Okoh et al. Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells
Mižíková et al. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts
Brunton et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies
Qin et al. Pyrroloquinoline quinone prevents knee osteoarthritis by inhibiting oxidative stress and chondrocyte senescence
Poston et al. Statin intake is associated with MMP‐1 level in gingival crevicular fluid of patients with periodontitis
Borges et al. Exercise training attenuates ubiquitin-proteasome pathway and increases the genes related to autophagy on the skeletal muscle of patients with inflammatory myopathies
AR127708A1 (es) Método para detectar biomarcadores de arn
Ko et al. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease
Lin et al. Acute dyskerin depletion triggers cellular senescence and renders osteosarcoma cells resistant to genotoxic stress-induced apoptosis
Huisman et al. Influence of repetitive mechanical loading on MMP2 activity in tendon fibroblasts
Tian et al. Decoding liver injury: a regulatory role for histone modifications
Cai et al. A cross-talk between NFAT and NF-κB pathways is crucial for nickel-induced COX-2 expression in Beas-2B cells